Skip to content

mHealth management against hypertension: a multicentre randomised controlled study

Mobile health management against hypertension: a multicenter randomized controlled study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500099307
Enrollment
Unknown
Registered
2025-03-21
Start date
2025-03-27
Completion date
Unknown
Last updated
2025-03-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypertension

Interventions

Digital Mobile Health Management Group:Digital mobile health management group: On the basis of treating and managing the enrolled patients in accordance with the current domestic clinical diagnosis an
Conventional treatment group :The conventional treatment group: Patients enrolled in this group were managed and treated according to the current domestic clinical guidelines for hypertension. This in

Sponsors

The First A ffiliated Hospital of Bengbu Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 90 Years

Inclusion criteria

Inclusion criteria: 1.Age range of 18-90 years, both males and females; 2.Agree to participate in a 12-month intervention program and commit to not withdrawing from the study during the next 12 months because of extended leave, going abroad, or other reasons; 3.Has assessed the patient's suitability for a 12-month lifestyle change program; 4.Have signed a written informed consent form.

Exclusion criteria

Exclusion criteria: 1.Pregnant or lactating women; 2.Patients with severe cardiovascular complications such as chronic systolic heart failure in the decompensated stage (NYHA cardiac function class =3) and cardiogenic shock; 3.Patients with severe gastrointestinal diseases, liver and kidney failure; 4.Cancer patients or patients who have received radiation therapy or chemotherapy within five years; 5.Patients with infectious diseases such as AIDS and tuberculosis; 6.Those who are hospitalized or suffering from other serious diseases requiring immediate hospitalization; 7.Bad habits: drug use or alcoholism (alcohol intake >80 grams/day for men and >40 grams/day for women); 8.Persons with impaired consciousness, inability to communicate normally, or any mental illness; persons who are unable to take care of themselves or have limited mobility; 9.Persons with a life expectancy of <12 months; 10.Individuals with abnormal laboratory tests and clinical manifestations who were judged by the investigator to be unsuitable for participation; 11.Unwilling to participate in the study and change the current drug treatment.

Design outcomes

Primary

MeasureTime frame
Home blood pressure levels ;24-hour ambulatory blood pressure levels ;Office blood pressure levels ;Psychological state;Sleep quality;Lifestyle changes ;Cognitive functioning;Degree of frailty;BMI ;Blood lipid level ;Cardiac death ;Blood pressure variability;

Secondary

MeasureTime frame
Nonfatal myocardial infarction ;Atrial fibrillation ;Hypertension readmission to hospital ;Hypertension readmission to hospital ;Renal insufficiency ;Nonfatal myocardial infarctio;

Countries

China

Contacts

Public ContactLiu Jinjun

The First Affiliated Hospital of Bengbu Medical College

byyfyliujinjun@163.com+86 178 5613 1299

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Apr 17, 2026